BamSEC and AlphaSense Join Forces
Learn More

Tourmaline Bio Inc.

NASDAQ: TRML    
Share price (12/23/24): $21.30    
Market cap (12/23/24): $546 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1
from 10-Q 6 pages Tourmaline Bio, Inc
12/34/56
EX-10.1
from 10-Q 3 pages Tourmaline Bio, Inc. Non-Employee Director Compensation Policy Originally Adopted: October 23, 2023 Amended and Restated: April 3, 2024
12/34/56
EX-10.14
from 10-Q 1 page November 9, 2023 Ryan Robinson 28 Winship Drive Stoneham, Ma 02180 Re: Interim CFO – Additional Compensation Dear Ryan: Sincerely, /S/ Sandeep Kulkarni Name: Sandeep Kulkarni Title: Chief Executive Officer Accepted: /S/ Ryan Robinson 11/10/2023 Ryan Robinson Date
12/34/56
EX-10.2
from 8-K 3 pages Tourmaline Bio, Inc. Non-Employee Director Compensation Policy Adopted: October 23, 2023
12/34/56
EX-10.1
from 8-K 20 pages Tourmaline Bio, Inc. Executive Severance and Change in Control Plan Effective Date: October 23, 2023
12/34/56
EX-10.10
from 8-K 13 pages Tourmaline Bio, Inc. 2023 Employee Stock Purchase Plan Adopted by the Board of Directors: June 22, 2023 Approved by the Stockholders: October 17, 2023
12/34/56
EX-10.9
from 8-K 7 pages Tourmaline Bio, Inc. Rsu Award Grant Notice
12/34/56
EX-10.8
from 8-K 8 pages Tourmaline Bio, Inc. Stock Option Grant Notice
12/34/56
EX-10.7
from 8-K 34 pages Tourmaline Bio, Inc. 2023 Equity Incentive Plan Adopted by the Board of Directors: June 22, 2023 Approved by the Stockholders: October 17, 2023
12/34/56
EX-10.5
from 8-K 2 pages Offer Letter
12/34/56
EX-10.4
from 8-K 6 pages Tourmaline Bio, Inc
12/34/56
EX-10.3
from 8-K 6 pages Tourmaline Bio, Inc
12/34/56
EX-10.2
from 8-K 5 pages Tourmaline Bio, Inc
12/34/56
EX-10.22
from S-4/A 1 page August 25, 2023 Scott Requadt Re: Amendment to Strategic Advisor Agreement Dear Scott
12/34/56
EX-10.6
from S-4 14 pages Indemnification Agreement
12/34/56
EX-10.15
from S-4 6 pages Strategic Advisor Agreement
12/34/56
EX-10.5
from S-4 22 pages Licence Agreement Between Lonza Sales AG and Tourmaline Bio, LLC
12/34/56
EX-10.4
from S-4 45 pages License Agreement
12/34/56
EX-10.1
from S-4 88 pages Tourmaline Bio, Inc. 2022 Equity Incentive Plan Adopted by the Board of Directors: September 2, 2022 Approved by the Stockholders: September 2, 2022 Amended by the Board of Directors: February 3, 2023 Termination Date: September 1, 2032
12/34/56
EX-10.3
from 8-K 5 pages Lock-Up Agreement
12/34/56